Found: 7
Select item for more details and to access through your institution.
Isolated congenital asplenia: An overlooked cause of thrombocytosis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. 1110, doi. 10.1002/ajh.26522
- By:
- Publication type:
- Article
Second cancers in MPN: Survival analysis from an international study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 295, doi. 10.1002/ajh.25700
- By:
- Publication type:
- Article
Ruxolitinib treatment and risk of B‐cell lymphomas in myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 7, p. E185, doi. 10.1002/ajh.25489
- By:
- Publication type:
- Article
Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms.
- Published in:
- EJHaem, 2022, v. 3, n. 2, p. 475, doi. 10.1002/jha2.425
- By:
- Publication type:
- Article
COVID-19 in Patients with Hematologic Diseases.
- Published in:
- Biomedicines, 2022, v. 10, n. 12, p. 3069, doi. 10.3390/biomedicines10123069
- By:
- Publication type:
- Article
Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosis.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 589, doi. 10.1002/hon.2903
- By:
- Publication type:
- Article
Impaired virus‐specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 4, p. 554, doi. 10.1002/hon.2769
- By:
- Publication type:
- Article